428 related articles for article (PubMed ID: 33548045)
1. Adenosine A
Massari CM; Constantino LC; Tasca CI
Purinergic Signal; 2021 Jun; 17(2):247-254. PubMed ID: 33548045
[TBL] [Abstract][Full Text] [Related]
2. Involvement of adenosine A
Massari CM; Constantino LC; Marques NF; Binder LB; Valle-León M; López-Cano M; Fernández-Dueñas V; Ciruela F; Tasca CI
Purinergic Signal; 2020 Sep; 16(3):379-387. PubMed ID: 32725400
[TBL] [Abstract][Full Text] [Related]
3. Guanosine Protects Striatal Slices Against 6-OHDA-Induced Oxidative Damage, Mitochondrial Dysfunction, and ATP Depletion.
Marques NF; Massari CM; Tasca CI
Neurotox Res; 2019 Feb; 35(2):475-483. PubMed ID: 30417317
[TBL] [Abstract][Full Text] [Related]
4. Guanosine-Mediated Anxiolytic-Like Effect: Interplay with Adenosine A
Frinchi M; Verdi V; Plescia F; Ciruela F; Grillo M; Garozzo R; Condorelli DF; Di Iorio P; Caciagli F; Ciccarelli R; Belluardo N; Di Liberto V; Mudò G
Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33291390
[TBL] [Abstract][Full Text] [Related]
5. Adenosine A
Lanznaster D; Massari CM; Marková V; Šimková T; Duroux R; Jacobson KA; Fernández-Dueñas V; Tasca CI; Ciruela F
Cells; 2019 Dec; 8(12):. PubMed ID: 31847113
[TBL] [Abstract][Full Text] [Related]
6. A
Gerbatin RR; Dobrachinski F; Cassol G; Soares FAA; Royes LFF
Neurosci Lett; 2019 Jun; 704():141-144. PubMed ID: 30974229
[TBL] [Abstract][Full Text] [Related]
7. The antidepressant-like effect of guanosine involves the modulation of adenosine A
Camargo A; Bettio LEB; Rosa PB; Rosa JM; Altê GA; Rodrigues ALS
Purinergic Signal; 2023 Jun; 19(2):387-399. PubMed ID: 36166131
[TBL] [Abstract][Full Text] [Related]
8. Guanosine controls inflammatory pathways to afford neuroprotection of hippocampal slices under oxygen and glucose deprivation conditions.
Dal-Cim T; Ludka FK; Martins WC; Reginato C; Parada E; Egea J; López MG; Tasca CI
J Neurochem; 2013 Aug; 126(4):437-50. PubMed ID: 23713463
[TBL] [Abstract][Full Text] [Related]
9. Guanosine prevents depressive-like behaviors in rats following bilateral dorsolateral striatum lesion induced by 6-hydroxydopamine.
Marques NF; Binder LB; Roversi K; Sampaio TB; Constantino LC; Prediger RD; Tasca CI
Behav Brain Res; 2019 Oct; 372():112014. PubMed ID: 31212060
[TBL] [Abstract][Full Text] [Related]
10. In vitro 6-hydroxydopamine-induced toxicity in striatal, cerebrocortical and hippocampal slices is attenuated by atorvastatin and MK-801.
Massari CM; Castro AA; Dal-Cim T; Lanznaster D; Tasca CI
Toxicol In Vitro; 2016 Dec; 37():162-168. PubMed ID: 27647473
[TBL] [Abstract][Full Text] [Related]
11. Dual blockade of the A1 and A2A adenosine receptor prevents amyloid beta toxicity in neuroblastoma cells exposed to aluminum chloride.
Giunta S; Andriolo V; Castorina A
Int J Biochem Cell Biol; 2014 Sep; 54():122-36. PubMed ID: 25058312
[TBL] [Abstract][Full Text] [Related]
12. Guanosine protects glial cells against 6-hydroxydopamine toxicity.
Giuliani P; Ballerini P; Buccella S; Ciccarelli R; Rathbone MP; Romano S; D'Alimonte I; Caciagli F; Di Iorio P; Pokorski M
Adv Exp Med Biol; 2015; 837():23-33. PubMed ID: 25310956
[TBL] [Abstract][Full Text] [Related]
13. Functional interplay between adenosine A
Constantino LC; Pamplona FA; Matheus FC; de Carvalho CR; Ludka FK; Massari CM; Boeck CR; Prediger RD; Tasca CI
Neurobiol Learn Mem; 2021 Apr; 180():107422. PubMed ID: 33691195
[TBL] [Abstract][Full Text] [Related]
14. Enhanced ATP release and CD73-mediated adenosine formation sustain adenosine A
Carmo M; Gonçalves FQ; Canas PM; Oses JP; Fernandes FD; Duarte FV; Palmeira CM; Tomé AR; Agostinho P; Andrade GM; Cunha RA
Br J Pharmacol; 2019 Sep; 176(18):3666-3680. PubMed ID: 31220343
[TBL] [Abstract][Full Text] [Related]
15. Presymptomatic and symptomatic ALS SOD1(G93A) mice differ in adenosine A1 and A2A receptor-mediated tonic modulation of neuromuscular transmission.
Nascimento F; Sebastião AM; Ribeiro JA
Purinergic Signal; 2015 Dec; 11(4):471-80. PubMed ID: 26335190
[TBL] [Abstract][Full Text] [Related]
16. JNJ-40255293, a novel adenosine A2A/A1 antagonist with efficacy in preclinical models of Parkinson's disease.
Atack JR; Shook BC; Rassnick S; Jackson PF; Rhodes K; Drinkenburg WH; Ahnaou A; Te Riele P; Langlois X; Hrupka B; De Haes P; Hendrickx H; Aerts N; Hens K; Wellens A; Vermeire J; Megens AA
ACS Chem Neurosci; 2014 Oct; 5(10):1005-19. PubMed ID: 25203719
[TBL] [Abstract][Full Text] [Related]
17. Caffeine and a selective adenosine A2A receptor antagonist induce sensitization and cross-sensitization behavior associated with increased striatal dopamine in mice.
Hsu CW; Wang CS; Chiu TH
J Biomed Sci; 2010 Jan; 17(1):4. PubMed ID: 20074377
[TBL] [Abstract][Full Text] [Related]
18. Adenosine receptors: regulatory players in the preservation of mitochondrial function induced by ischemic preconditioning of rat liver.
Duarte FV; Amorim JA; Varela AT; Teodoro JS; Gomes AP; Cunha RA; Palmeira CM; Rolo AP
Purinergic Signal; 2017 Jun; 13(2):179-190. PubMed ID: 27848069
[TBL] [Abstract][Full Text] [Related]
19. Altered adenosine 2A and dopamine D2 receptor availability in the 6-hydroxydopamine-treated rats with and without levodopa-induced dyskinesia.
Zhou X; Doorduin J; Elsinga PH; Dierckx RAJO; de Vries EFJ; Casteels C
Neuroimage; 2017 Aug; 157():209-218. PubMed ID: 28583881
[TBL] [Abstract][Full Text] [Related]
20. A role for adenosine A(1) receptor blockade in the ability of caffeine to promote MDMA "Ecstasy"-induced striatal dopamine release.
Vanattou-Saïfoudine N; Gossen A; Harkin A;
Eur J Pharmacol; 2011 Jan; 650(1):220-8. PubMed ID: 20951694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
